Hallmarks of liver cancer: Therapeutic implications

Josep M. Llovet, Roser Pinyol, Silvia Affo, Mark Yarchoan, Gregory J. Gores, Robin Kate Kelley, Scott W. Lowe, Daniela Sia, Augusto Villanueva

Open source

DOI
10.1016/j.cell.2026.03.001
Published
2026-04
Container
Cell
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cell.2026.03.001,
  title = {Hallmarks of liver cancer: Therapeutic implications},
  author = {Josep M. Llovet and Roser Pinyol and Silvia Affo and Mark Yarchoan and Gregory J. Gores and Robin Kate Kelley and Scott W. Lowe and Daniela Sia and Augusto Villanueva},
  year = {2026},
  journal = {Cell},
  doi = {10.1016/j.cell.2026.03.001},
  url = {https://doi.org/10.1016/j.cell.2026.03.001}
}

RIS

TY  - JOUR
TI  - Hallmarks of liver cancer: Therapeutic implications
AU  - Josep M. Llovet
AU  - Roser Pinyol
AU  - Silvia Affo
AU  - Mark Yarchoan
AU  - Gregory J. Gores
AU  - Robin Kate Kelley
AU  - Scott W. Lowe
AU  - Daniela Sia
AU  - Augusto Villanueva
PY  - 2026
JO  - Cell
DO  - 10.1016/j.cell.2026.03.001
UR  - https://doi.org/10.1016/j.cell.2026.03.001
ER  - 

APA

Llovet, J. M., Pinyol, R., Affo, S., Yarchoan, M., Gores, G. J., Kelley, R. K., Lowe, S. W., Sia, D., & Villanueva, A. (2026). Hallmarks of liver cancer: Therapeutic implications. Cell. https://doi.org/10.1016/j.cell.2026.03.001

Source records